Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis

Peritoneal Dialysis International

Volumn 21, Issue 5, 2001, Pages 471-479

  Ritzau, J ^a   Hoffman, R M ^a   Tzamaloukas, A H ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Catheter loss; Exit site infection; Mupirocin; Peritonitis; Rifampin; Staphylococcus aureus; Tunnel infection

Indexed keywords

PLACEBO; PSEUDOMONIC ACID; RIFAMPICIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EVALUATION; FOLLOW UP; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL LITERATURE; NOSE; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0034771827     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102100508     Document Type: Article

References (48)

1. Staphylococcus aureus peritoneal catheter related infections: A cause of catheter loss and peritonitis
2. Exit site infection in continuous ambulatory peritoneal dialysis: A review
3. Management of catheter related infections
4. Peritonitis
5. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients
6. Staphylococcus aureus nasal carriage and subsequent infection in peritoneal dialysis patients
7. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis
8. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis
9. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients
10. Staphylococcus aureus CAPD-related infections are associated with nasal carriage
11. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: A prospective study
12. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centers in Denmark
13. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis
14. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections
15. New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients
16. Staphylococcus aureus nasal carriage is not associated with increased incidence of exit-site infection with the same organism
17. Carrier-status for nasal staphylococci does not predict infections in CAPD patients
18. Searching for evidence-based medical practice
19. New approaches to reduce Staphylococcus aureus nosocomial infection rates: Treating S. aureus nasal carriage
20. Evidence-based recommendations for the management of glomerulonephritis
21. Prognostic factors associated with the first episode of peritonitis
22. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems
23. Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis
24. The effect of body weight on CAPD related infections and catheter loss
25. Vaccination for prevention of CAPD associated staphylococcal infection: Results of a prospective multicentre clinical trial
26. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis
27. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis
28. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin
29. Preventing Staphylococcus aureus infection during chronic peritoneal dialysis
30. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site
31. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results
32. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis
33. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis
34. Outcome and clinical implications of a surveillance program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients
35. Application of mupirocin cream at the catheter exit site reduces exit-site infection and peritonitis in peritoneal dialysis patients
36. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin
37. Prophylactic cephalexin is ineffective in chronic ambulatory peritoneal dialysis
38. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients: A randomized prospective clinical trial of cotrimazole prophylaxis
39. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: Silver ring prophylaxis of the catheter exit site
40. Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters
41. Active intervention dramatically reduces CAPD-associated infection
42. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infection. Results unaffected by routine mupirocin treatment of nasal S. aureus carriage
43. Resistance to mupirocin: No indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients
44. Mupirocin (Bactroban) causes permanent structural changes in peritoneal dialysis catheters
45. Unusual complications of a polyurethane PD catheter
46. The treatment of Staphylococcus aureus nasal carriage in pediatric dialysis patients
47. Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis
48. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized placebo-controlled trial